Mraz, Amerine & Associates, Inc. Amgen Inc Transaction History

Mraz, Amerine & Associates, Inc.

$521 Million
Q3 2024

A detailed history of Mraz, Amerine & Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Mraz, Amerine & Associates, Inc. holds 7,024 shares of AMGN stock, worth $2.22 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

7,024

Previous 7,024 -0.0%

Holding current value

$2.22 Million

Previous $2.19 Million 3.14%

% of portfolio

0.43%

Previous 0.48%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $151,606 - $184,241	577 Added 8.95%	7,024 $2.19 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $101,095 - $122,034	376 Added 6.19%	6,447 $1.83 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.02%	6,071 $1.75 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $104,514 - $129,757	478 Added 8.55%	6,070 $1.63 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $24,641 - $29,137	-115 Reduced 2.02%	5,592 $1.24 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $116,281 - $141,728	515 Added 9.92%	5,707 $1.38 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $11,535 - $12,837	-50 Reduced 0.95%	5,192 $1.26 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.02%	5,242 $1.27 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $21,638 - $25,767	-100 Reduced 1.87%	5,241 $1.21 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $234 - $260	1 Added 0.02%	5,341 $1.36 Million
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $106,817 - $131,079	-540 Reduced 9.18%	5,340 $1.26 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $78,363 - $103,931	430 Added 7.89%	5,880 $1.19 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $9,460 - $12,160	-50 Reduced 0.91%	5,450 $1.31 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $2,089 - $2,503	12 Added 0.22%	5,500 $1.06 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $82,838 - $93,377	-458 Reduced 7.7%	5,488 $1.04 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $8,920 - $10,412	-50 Reduced 0.83%	5,946 $1.16 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $185 - $208	1 Added 0.02%	5,996 $1.24 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $49,815 - $55,953	300 Added 5.27%	5,995 $1.11 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $115,212 - $134,640	-680 Reduced 10.67%	5,695 $971,000
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $24,980 - $27,911	-148 Reduced 2.27%	6,375 $1.11 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $1.09 Million - $1.25 Million	6,523	6,523 $1.22 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mraz, Amerine & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mraz, Amerine & Associates, Inc. with notifications on news.

Account

Mraz, Amerine & Associates, Inc. Amgen Inc Transaction History